[French guidelines for sweat test practice and interpretation for cystic fibrosis neonatal screening].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Archives de pédiatrie

• Publication date

  2010-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.arcped.2010.06.021PMID 20719482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis

  2010cited by this paper
• Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up.

  2010cited by this paper
• Questions soulevées et réponses apportées depuis la généralisation du dépistage néonatal de la mucoviscidose en France

  2009cited by this paper
• A reference interval for sweat chloride in infants aged between five and six weeks of age

  2009cited by this paper
• European best practice guidelines for cystic fibrosis neonatal screening.

  2009cited by this paper
• Sweat testing for cystic fibrosis: standards of performance in Australasia

  2009cited by this paper
• A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

  2009cited by this paper
• Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis

  2009cited by this paper
• Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report.

  2008cited by this paper
• Implementation of the French nationwide cystic fibrosis newborn screening program.

  2008cited by this paper
• Nanoduct® sweat testing for rapid diagnosis in newborns, infants and children with cystic fibrosis

  2008cited by this paper
• Sweat chloride testing in infants identified as heterozygote carriers by newborn screening.

  2008cited by this paper
• Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations

  2007cited by this paper
• Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines.

  2007cited by this paper
• Guidelines for Implementation of Cystic Fibrosis Newborn Screening Programs: Cystic Fibrosis Foundation Workshop Report

  2007cited by this paper
• Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis

  2007cited by this paper
• The evaluation of a novel conductometric device for the diagnosis of cystic fibrosis

  2006cited by this paper
• Sweat testing infants detected by cystic fibrosis newborn screening.

  2005cited by this paper
• Sweat‐testing in preterm and full‐term infants less than 6 weeks of age

  2005cited by this paper
• Information flow after a positive newborn screening for cystic fibrosis.

  2005cited by this paper
• Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.

  2005cited by this paper
• Cystic fibrosis: terminology and diagnostic algorithms

  2005cited by this paper
• Psychosocial Risk Associated With Newborn Screening for Cystic Fibrosis: Parents’ Experience While Awaiting the Sweat-Test Appointment

  2005cited by this paper
• Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.

  2005cited by this paper
• Cystic fibrosis.

  2005cited by this paper
• Testing diagnostic tests: why size matters.

  2005cited by this paper
• Diagnosis of cystic fibrosis after newborn screening: The Australasian experience—twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory group

  2005cited by this paper
• Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis.

  2005cited by this paper
• Sweat‐testing: A review of current technical requirements

  2005cited by this paper
• Sweat testing in newborns positive to neonatal screening for cystic fibrosis

  2004cited by this paper
• Sweat conductivity and chloride titration for cystic fibrosis diagnosis in 3834 subjects.

  2003cited by this paper
• CFTR genotypes in patients with normal or borderline sweat chloride levels

  2003cited by this paper
• Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK

  2003cited by this paper
• Biological variation in sweat sodium chloride conductivity

  2002cited by this paper
• Sweat testing following newborn screening for cystic fibrosis

  2000cited by this paper
• Un test de la sueur normal n'exclut pas le diagnostic de mucoviscidose

  2000cited by this paper
• Sweat analysis proficiency testing for cystic fibrosis

  2000cited by this paper
• Reliability of sweat‐testing by the Macroduct® collection method combined with conductivity analysis in comparison with the classic Gibson and Cooke technique

  2000cited by this paper
• [Sweat test].

  1998cited by this paper
• Le test de la sueur

  1998cited by this paper
• Comment, quand et pourquoi demander un test de la sueur en 1997 ?

  1998cited by this paper
• Baby with eczema and abnormal sweat test.

  1996cited by this paper
• Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.

  1996cited by this paper
• Sweat testing for the diagnosis of cystic fibrosis: practical considerations.

  1996cited by this paper
• Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis.

  1995cited by this paper
• Clinical evaluation of the macroduct sweat collection system and conductivity analyzer in the diagnosis of cystic fibrosis.

  1994cited by this paper
• Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.

  1991cited by this paper
• Misdiagnosis of Cystic Fibrosis

  1987cited by this paper
• Chloride impermeability in cystic fibrosis

  1983cited by this paper
• Cooperative study comparing three methods of performing sweat tests to diagnose cystic fibrosis.

  1980cited by this paper
• Sweat tests in the newborn period.

  1973cited by this paper
• A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

  1959cited by this paper
• Mucoviscidosis.

  1955cited by this paper
• Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas.

  1953cited by this paper
• Abnormal electrolyte composition of sweat in cystic fibrosis of the pancreas; clinical significance and relationship to the disease.

  1953cited by this paper
• A SIMPLE AND ACCURATE METHOD FOR THE DETERMINATION OF CHLORIDE IN BIOLOGICAL FLUIDS

  1941cited by this paper

• Initial characteristics of cystic fibrosis in Algeria: Description of 34 pediatric cases

  2024cites this paper
• Long-Term Outcomes in Real Life of Lumacaftor–Ivacaftor Treatment in Adolescents With Cystic Fibrosis

  2021cites this paper
• Sweat Testing and Recent Advances

  2021cites this paper
• Newborn screening for CF in France: An exemplary national experience.

  2020cites this paper
• Current and future diagnosis of cystic fibrosis: Performance and limitations.

  2020cites this paper
• Sweat chloride quantification using capillary electrophoresis

  2018cites this paper
• Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening.

  2017cites this paper
• [Management of infants whose diagnosis is inconclusive at neonatal screening for cystic fibrosis].

  2017cites this paper
• Real life practice of sweat testing in Europe.

  2017cites this paper
• Mucoviscidose de l’adulte

  2016cites this paper
• A candidate reference method using ICP-MS for sweat chloride quantification

  2016cites this paper
• Contribution of M470V variant to cystic fibrosis: First study in CF and normal Tunisian population.

  2015cites this paper
• Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy

  2015cites this paper
• Test de la sueur

  2015cites this paper
• Sweat test practice in pediatric pulmonology after introduction of cystic fibrosis newborn screening

  2015cites this paper
• Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.

  2014cites this paper
• Sixty‐five years since the New York heat wave: Advances in sweat testing for cystic fibrosis

  2014cites this paper
• Comprehensive CFTR gene analysis of the French cystic fibrosis screened newborn cohort: implications for diagnosis, genetic counseling, and mutation-specific therapy

  2014cites this paper
• Electrochemical detection of chloride levels in sweat using silver nanoparticles: a basis for the preliminary screening for cystic fibrosis.

  2013cites this paper
• [Sweat chloride measurement using direct potentiometry: Spotchem(®) (Elitech-Arkray) evaluation and comparison with coulometry and conductivity].

  2013cites this paper
• [Analytical quality of assays and comparison of procedures for the sweat test].

  2012cites this paper
• Bone loss in adults with cystic fibrosis: prevalence, associated factors, and usefulness of biological markers.

  2012cites this paper
• Retentissement osseux de la mucoviscidose de l’adulte ☆

  2012cites this paper
• L'expérience professionnelle du médecin hospitalier à l'épreuve du dépistage : le cas de l'annonce du diagnostic de la mucoviscidose

  2011cites this paper
• Contribution à l’amélioration des connaissances sur la relation génotype-phénotype dans la mucoviscidose et caractérisation phénotypique de l’inflammation pulmonaire

  2011cites this paper
• Chapitre 26 – Pathologie respiratoire

  2011cites this paper